Identification of an Individualized Metabolism Prognostic Signature and Related Therapy Regimens in Early Stage Lung Adenocarcinoma

Identification of an Individualized Metabolism Prognostic Signature and Related Therapy Regimens in Early Stage Lung Adenocarcinoma

ObjectiveThe choice of adjuvant therapy for early stage lung adenocarcinoma (LUAD) remains controversial. Identifying the metabolism characteristics leading to worse prognosis may have clinical utility in offering adjuvant therapy.MethodsThe gene expression profiles of LUAD were collected from 22 pu...

Full description

Bibliographic Details
Main Authors: Junjie Hu, Huansha Yu, Liangdong Sun, Yilv Yan, Lele Zhang, Gening Jiang, Peng Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Oncology
Subjects:
lung adenocarcinoma
early stage
metabolism genes
prognostic signature
adjuvant therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.650853/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.650853/full

Similar Items